David M. Davies

Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

Scott Wilkie, May CI van Schalkwyk, Steve Hobbs et al. · Journal of Clinical Immunology · 2012 · 480 citations

Breast Oncology, Medicine, Dual Targeting +6

Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor

Scott Wilkie, Gianfranco Picco, Julie Foster et al. · The Journal of Immunology · 2008 · 344 citations · Full text

Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4

Scott Wilkie, S. Burbridge, Laura Chiapero-Stanke et al. · Journal of Biological Chemistry · 2010 · 190 citations · Full text

Immunology, Il-4 Receptor Alpha, Immunologic Mechanism +16

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

Lynsey M. Whilding, Leena Halim, Benjamin Draper et al. · Cancers · 2019 · 188 citations · Full text

Several Solid Malignancies, Immunology, Immune Regulation +23

Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors

Paris Kosti, James W. Opzoomer, Karen I. Larios-Martinez et al. · Cell Reports Medicine · 2021 · 131 citations · Full text